|
Dear
fellow
South
Carolinians,
Thank
you
for
subscribing
to
my
weekly
e-newsletter,
and
please
remember
to
follow
me
on Facebook, Twitter, Instagram and YouTube.
Women’s
History
Month
With
the
arrival
of
March
comes
the
celebration
of
Women’s
History
Month.
Some
of
the
wonderful
women
on
my
staff
and
I
took
a
moment
last
week
to
thank
those
women
–
past,
present,
and
future
–
who
make
our
world
turn.
You
can
check
it
out
here.
HBCU
Second
Annual
Fly-In
Last
Tuesday,
I
was
proud
to
host
our
Second
Annual
HBCU
Fly-In
with
Rep.
Mark
Walker
in
Washington,
D.C.
It
was
great
to
welcome
so
many
schools,
including
South
Carolina
State
University,
Claflin
University,
Benedict
College,
and
Allen
University. We
were
also
happy
that
Google,
John
Deere,
Wal-Mart,
Bank
of
America,
Starbucks,
and
McDonald’s
joined
us
for
a
productive
discussion
on
advancing
opportunity
and
entrepreneurship.
Our
keynote
speaker,
Baltimore
Raven's
TE
Benjamin
Watson,
also
delivered
an
inspiring
speech
on
expanding
and
creating
opportunities.
We
closed
the
day
with
a
bipartisan
member
panel,
moderated
by
the
White
House’s
Ja’Ron
Smith.
 
Sickle
Cell
Disease
Research,
Surveillance,
Prevention
and
Treatment
Act
Last
Wednesday,
I
introduced
a
new
bipartisan
initiative
in
the
fight
against
Sickle
Cell
Disease
–
the
Sickle
Cell
Disease
Research,
Surveillance,
Prevention
and
Treatment
Act.
There
is
currently
no
national
framework
in
place
to
accurately
measure
the
current
number
of
Americans
affected
by
SCD,
and
this
new
bipartisan
legislation
would
increase
efforts
to
collect
data
on
the
disease
and
reauthorize
the
Sickle
Cell
Disease
Treatment
Demonstration
Program
(SDTDP).
It
is
critical
that
we
understand
the
full
breadth
of
what
we’re
facing
in
the
fight
to
cure
Sickle
Cell
Disease.
This
legislation
marks
a
significant
step
forward
in
our
efforts
to
combat
Sickle
Cell
on
all
fronts
–
research,
surveillance,
prevention
and
treatment.
We
owe
it
to
those
suffering
every
day
to
do
everything
possible
to
find
a
cure.
You
can
read
more
here.
Sincerely,
Tim |